Muhammad Alamgeer

Wellington Road
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Prognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis.

Prognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis.

Journal: Annals of medicine

Published: August 21, 2026

FRailty in Australian patients admitted to Intensive care unit after eLective CANCER-related SURGery: a retrospective multicentre cohort study (FRAIL-CANCER-SURG study).

FRailty in Australian patients admitted to Intensive care unit after eLective CANCER-related SURGery: a retrospective multicentre cohort study (FRAIL-CANCER-SURG study).

Journal: British journal of anaesthesia

Published: November 20, 2023

Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey.

Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey.

Journal: Australian critical care : official journal of the Confederation of Australian Critical Care Nurses

Published: September 10, 2023

Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study.

Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study.

Journal: The lancet. Healthy longevity

Published: July 20, 2023

Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

Journal: Heart, lung & circulation

Published: May 28, 2023

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.

Journal: The Medical journal of Australia

Published: May 11, 2023

Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis.

Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: March 18, 2023

Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy.

Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy.

Journal: JTO clinical and research reports

Published: March 06, 2023

MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.

MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 10, 2023

Treatment outcomes of standard (high dose) cisplatin and non-standard chemotherapy for locally advanced head and neck cancer.

Treatment outcomes of standard (high dose) cisplatin and non-standard chemotherapy for locally advanced head and neck cancer.

Journal: Cancer reports (Hoboken, N.J.)

Published: February 06, 2022

Estimating the impact of COVID-19-induced coagulopathy.

Estimating the impact of COVID-19-induced coagulopathy.

Journal: Annals of the Academy of Medicine, Singapore

Published: May 15, 2021

Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.

Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.

Journal: Translational lung cancer research

Published: July 18, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026